Delivery Order SPE2DB24D2100-SPE2DB25FBEJA
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BIMZELX 160 MG/ML AUTOINJECTORML. The contract has a firm fixed price of $9,783.88 and a completion date of May 22, 2025. The contract is not set aside and is for open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,588.45, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract is a firm fixed-price delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,544.73, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. This award is not a set-aside contract. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $25,549.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication BIMZELX 160 MG/ML AUTOINJECTORML, with a performance period ending on May 2, 2025. The contract is a firm fixed-price agreement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BIMZELX 160 MG/ML AUTOINJECTORML. The contract has a ceiling value of $10,594.68 and an ultimate completion date of May 23, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp also holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with the ID SPE2DX15D3005|SPE2DX24F3SPG, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,187.00, is a Firm Fixed Price Delivery Order for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has a period of performance through July 5, 2024. Amerisourcebergen Drug Corp is the prime contractor...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BIMZELX 320 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a ceiling value of $23,436.63 and a period of performance through May 6, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $554,521.18, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,540.48, is for the provision of a variety of pharmaceutical products and medical supplies to support military healthcare programs. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $14,623.74 and a period of performance through April 29, 2025. It is a firm fixed-price contract for the delivery of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...